Pignata S

ORCID: 0000-0002-8836-2633 · 5 papers in corpus
2026
Clinical and translational medicine ·doi:10.1002/ctm2.70591

Angiogenesis, driven by the vascular endothelial growth factor (VEGF)/VEGFR signalling axis under hypoxic conditions, is one of the hallmarks of ovarian cancer (OC), contributing to tumour progression, metastatic dissemination and immune ev…

other 2025
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology ·doi:10.1016/j.ejso.2025.110030

BACKGROUND: The Endometrioid Borderline ovarian tumor (EBOT) is the third most common histological subtype of borderline ovarian tumors. Due to the low incidence of disease, literature is scanty about the prognosis and management of this en…

review 2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1661048

Ovarian clear cell carcinoma (OCCC) is a rare, aggressive epithelial ovarian cancer subtype, accounting for approximately 10% of cases and associated with a poor prognosis due to chemoresistance and unique tumor biology. OCCC is frequently …

2022
Cancers ·doi:10.3390/cancers14205171

Intestinal-type adenocarcinoma (VAIt) represents a sporadic variant of vulvar carcinoma. It appears frequently localized to epithelial glands in the vulvar region, and it probably derives from cloacal remnants persisting in the adult. We pe…

2019
Cancers ·doi:10.3390/cancers11111820

Endometrial cancer (EC) is the most frequent gynecological cancer. In patients with relapsed and advanced disease, prognosis is still dismal and development of resistance is common. In this context, endometrial Cancer Stem Cells (eCSC), ste…